ATE261497T1 - Diagnostisches verfahren und gerät - Google Patents

Diagnostisches verfahren und gerät

Info

Publication number
ATE261497T1
ATE261497T1 AT97919516T AT97919516T ATE261497T1 AT E261497 T1 ATE261497 T1 AT E261497T1 AT 97919516 T AT97919516 T AT 97919516T AT 97919516 T AT97919516 T AT 97919516T AT E261497 T1 ATE261497 T1 AT E261497T1
Authority
AT
Austria
Prior art keywords
osteoarthritis
susceptibility
vitamin
individual
predisposition
Prior art date
Application number
AT97919516T
Other languages
English (en)
Inventor
Timothy David Spector
Richard William Keen
Original Assignee
Sequenom Gemini Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sequenom Gemini Ltd filed Critical Sequenom Gemini Ltd
Application granted granted Critical
Publication of ATE261497T1 publication Critical patent/ATE261497T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/125—Allele specific primer extension
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Air Bags (AREA)
AT97919516T 1996-04-19 1997-04-21 Diagnostisches verfahren und gerät ATE261497T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9608133.6A GB9608133D0 (en) 1996-04-19 1996-04-19 Diagnostic method and apparatus
PCT/GB1997/001107 WO1997040187A1 (en) 1996-04-19 1997-04-21 Diagnostic method and apparatus

Publications (1)

Publication Number Publication Date
ATE261497T1 true ATE261497T1 (de) 2004-03-15

Family

ID=10792346

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97919516T ATE261497T1 (de) 1996-04-19 1997-04-21 Diagnostisches verfahren und gerät

Country Status (10)

Country Link
US (1) US5939260A (de)
EP (2) EP0909330B1 (de)
JP (1) JP4275736B2 (de)
AT (1) ATE261497T1 (de)
AU (1) AU733426B2 (de)
CA (1) CA2251744C (de)
DE (1) DE69728044T2 (de)
GB (1) GB9608133D0 (de)
NZ (1) NZ332365A (de)
WO (1) WO1997040187A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9819769D0 (en) * 1998-09-10 1998-11-04 Oxagen Limited Method
GB9819764D0 (en) 1998-09-10 1998-11-04 Oxagen Limited Method
AU6110299A (en) * 1998-10-02 2000-04-26 Catalyst Biomedica Limited Susceptibility locus for osteoarthritis
AU6110599A (en) * 1998-10-02 2000-04-26 Catalyst Biomedica Limited Susceptibility locus for osteoarthritis
AU9756898A (en) * 1998-11-12 2000-06-05 Gemini Genomics Ab Human prostaglandin receptors and methods of use thereof
WO2000047770A1 (en) * 1999-02-15 2000-08-17 Catalyst Biomedica Ltd. Susceptibility locus for osteoarthritis
WO2000047769A1 (en) * 1999-02-15 2000-08-17 Catalyst Biomedica Ltd. Susceptibility locus for osteoarthritis
WO2002097109A2 (en) * 2001-05-25 2002-12-05 Invitrogen Corporation Compositions and methods for extension of nucleic acids
US7238475B2 (en) * 2001-08-27 2007-07-03 The Regents Of The University Of California Apolipoprotein gene involved in lipid metabolism
US7354712B2 (en) 2003-04-30 2008-04-08 Century Technology, Inc. Estrogen receptor alleles that are predictive of increased susceptibility to bone fracture
GB0408684D0 (en) * 2004-04-19 2004-05-19 Guy S And St Thomas Hospital N Diagnostic method
GB0408685D0 (en) * 2004-04-19 2004-05-19 Guys & St Thomas Hospital Trus Diagnostic method

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3016587B2 (ja) * 1989-12-04 2000-03-06 ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク 非ステロイド抗炎症剤及びテトラサイクリンの配合
DE69333659T2 (de) * 1992-07-31 2005-11-17 Garvan Institute Of Medical Research, Darlinghurst Einschätzung von in trans-agierenden faktoren der allelen variation
EP0765475A1 (de) * 1994-05-18 1997-04-02 Ligand Pharmaceuticals, Inc. Screening für cytokine-modulatoren
ES2252746T3 (es) * 1994-09-23 2006-05-16 Alexion Pharmaceuticals, Inc. Procedimientos para el tratamiento de la enfermedad inflamatoria articular.
GB9425487D0 (en) * 1994-12-16 1995-02-15 Res Inst Osteoarthritis treatment
US5591740A (en) * 1995-06-07 1997-01-07 Osteoarthritis Sciences, Incorporated Use of debromohymenialdisine for treating osteoarthritis
IT1276781B1 (it) * 1995-06-23 1997-11-03 Gentili Ist Spa Derivati antrachinonmono- e disolfon- sostituiti e composizioni farmaceutiche che li contengono per il trattamento delle patologie
US5698399A (en) * 1996-04-05 1997-12-16 Duff; Gordon W. Detecting genetic predisposition for osteoporosis

Also Published As

Publication number Publication date
JP2000508548A (ja) 2000-07-11
NZ332365A (en) 2000-06-23
EP1394273A1 (de) 2004-03-03
GB9608133D0 (en) 1996-06-26
DE69728044D1 (de) 2004-04-15
US5939260A (en) 1999-08-17
DE69728044T2 (de) 2004-10-28
EP0909330B1 (de) 2004-03-10
WO1997040187A1 (en) 1997-10-30
JP4275736B2 (ja) 2009-06-10
AU733426B2 (en) 2001-05-17
AU2395697A (en) 1997-11-12
CA2251744A1 (en) 1997-10-30
CA2251744C (en) 2008-01-15
EP0909330A1 (de) 1999-04-21

Similar Documents

Publication Publication Date Title
Schmidt et al. Molecular genetics of shyness and aggression in preschoolers
DE3381518D1 (de) Verfahren zur charakterisierung von hla und die darin benutzten cdns-testmittel.
FR2755149B1 (fr) Procede de diagnostic de maladies genetiques par peignage moleculaire et coffret de diagnostic
DE69728044D1 (de) Diagnostisches verfahren und gerät
DE60325617D1 (de) Verfahren zur diagnose von bauchspeicheldrüsenkrebs
ATE333517T1 (de) Verfahren und sondenset zur erkennung von krebs
DE60037300D1 (de) Verfahren und Vorrichtung zur modellbasierten Diagnose
DE60016178D1 (de) Verfahren zur diagnose und zur charakterisierung von schlaganfall
ATE194391T1 (de) Amplifikationsoligonukleotide und sonden für borrelia, die mit lyme kranheit assoziiert sind
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
ATE312198T1 (de) Diagnose und behandlung von supravalvular aortic stenosis
ATE215129T1 (de) Dna marker für die grösse eines ferkelwurfes
PL362437A1 (en) Diagnostics and therapeutics for glaucoma
EP1543331A4 (de) Verfahren zur diagnose von morbus alzheimer
DE69528703D1 (de) VERFAHREN, REAGENZIEN UND TESTSATZ ZUR DIAGNOSE UND GEZIELTE SIEBTESTUNG FÜR p53 MÜTATIONEN
DE69934983D1 (de) Verfahren, vorrichtung und bildgebungsmodus für tomographische bildgebung
DE69839750D1 (de) Verfahren und Vorrichtung für Diagnostik-Bilderzeugung
DE69816987D1 (de) Verfahren und zusammenstellungen zur identifiezierung von genetisch resistenten schweinen gegen f18 e. coli assozierte krankheiten
DE69710469D1 (de) Diagnoseverfahren und vorrichtung zum nachweis der prädisposition zu bestimmten krankheitszuständen, insbesondere osteoporose, auf basis von il-6 genpolymorphismus
EP1092783A4 (de) Verfahren zur krebsdiagnose auf basis des nachweises von chromosomenabnormalitäten
DE59912730D1 (de) Verfahren und vorrichtung zur automatisierten diagnose von diagnoseobjekten
EP0774970A4 (de) Verfahren zur verwendung von hyaluronsäure zur detektion, lokalisation und diagnose von tumoren
WO2004007762A3 (en) Genes associated with schizophrenia, adhd and bipolar disorders
DE69608462D1 (de) Mikrosatellitensequenzen zur bestimmung des genotyps von hunden
WO2001018240A3 (en) Diagnostic and therapeutic methods in autoimmune disease

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties